UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008430
Receipt number R000009918
Scientific Title CINV by MEC in clinical practice and rescue of it by NK1RA
Date of disclosure of the study information 2012/07/14
Last modified on 2019/05/31 10:28:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

CINV by MEC in clinical practice and rescue of it by NK1RA

Acronym

CINV by MEC and NK1RA

Scientific Title

CINV by MEC in clinical practice and rescue of it by NK1RA

Scientific Title:Acronym

CINV by MEC and NK1RA

Region

Japan


Condition

Condition

Lung cancer

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Frequency of CINV by MEC

Basic objectives2

Others

Basic objectives -Others

Efficacy and toxicity of rescue of CINV by aprepitant

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Frequency of CINV

Key secondary outcomes

Toxicity and efficacy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Oral aprepitant

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

MEC regimen for 1st cycle of line chomotherapy for lung cancer

Key exclusion criteria

Unable to intake aprepitant orally

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Fumio
Middle name
Last name Imamura

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Dept of Thoracic Oncology

Zip code

5418567

Address

1-3-3 Nakamichi Hagashinari-ku, Osaka 537-8511

TEL

6-6972-1181

Email

imamura-fu@mc.pref.osaka.jp


Public contact

Name of contact person

1st name Fumio
Middle name
Last name Imamura

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Dept of Thoracic Oncology

Zip code

5418567

Address

1-3-3 Nakamichi Hagashinari-ku, Osaka 537-8511

TEL

6-6972-1181

Homepage URL


Email

imamura-fu@mc.pref.osaka.jp


Sponsor or person

Institute

Osaka Medical Center for Cancer and Cardiovascular Diseases

Institute

Department

Personal name



Funding Source

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Address

1-3-3 Nakamichi Hagashinari-ku, Osaka 537-8511

Tel

0669721181

Email

imamura-fu@mc.pref.osaka.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪府立成人病センター


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 07 Month 13 Day

Date of IRB

2012 Year 07 Month 15 Day

Anticipated trial start date

2012 Year 07 Month 17 Day

Last follow-up date

2013 Year 08 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 07 Month 13 Day

Last modified on

2019 Year 05 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009918


Research Plan
Registered date File name
2018/01/16 イメンドrescue-ver2.doc

Research case data specifications
Registered date File name
2018/01/16 試験内容サマリ.docx

Research case data
Registered date File name